Tyra Biosciences TYRA
NASDAQ TYRA
$28.65 +3.79 (+15.30%)
As of: Sep 4, 2026 · 3:59 PM EDT

Tyra Biosciences (TYRA) Other Non-Current Assets (2020 - 2026)

Tyra Biosciences' (TYRA) quarterly Other Non-Current Assets came in at $1.0 million in Q1 2026, little changed YoY from $1.0 million in Q1 2025, and little changed on a QoQ basis from $1.0 million in Q4 2025.

Analysis

Tyra Biosciences (TYRA) Other Non-Current Assets (2020 - 2026) Analysis & Trends

Tyra Biosciences (TYRA) has 7 years of Other Non-Current Assets data on file, last reported at $1.0 million in Q1 2026.

  • Quarterly Other Non-Current Assets changed 0.0% year-over-year to $1.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.0 million (changed 0.0% YoY) and the FY2025 annual result came in at $1.0 million, down 86.44% from the prior year.
  • Other Non-Current Assets held at $1.0 million in Q1 2026, from $1.0 million in the prior quarter.
  • In the past five years, Other Non-Current Assets ranged from a high of $12.6 million in Q3 2025 to a low of $1.0 million in Q1 2022.
  • A 5-year average of $2.7 million and a median of $1.0 million in 2022 frame the typical range for Other Non-Current Assets.
  • Annual changes were most pronounced in 2022 — Other Non-Current Assets jumped 1690.12% — and 2025, when it slumped 86.44%.
  • Tracing TYRA's Other Non-Current Assets over 5 years: stood at $4.4 million in 2022, then grew by 15.68% to $5.0 million in 2023, then jumped by 46.58% to $7.4 million in 2024, then tumbled by 86.44% to $1.0 million in 2025, then changed by 0.0% to $1.0 million in 2026.
  • The last three Other Non-Current Assets figures came in at $1.0 million (Q1 2026), $1.0 million (Q4 2025), and $12.6 million (Q3 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 1.25 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 2.31 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 124.00 Mn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 618.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 42.45 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 109.58 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 65.13 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 62.96 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 104.44 Mn
10 Tyra Biosciences 1.94 Bn 1.94 Bn - 9.03 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 9.03 Mn
Mar 31, 2026 9.89 Mn
Dec 31, 2025 9.27 Mn
Sep 30, 2025 12.59 Mn
Jun 30, 2025 1.00 Mn
Mar 31, 2025 1.00 Mn
Dec 31, 2024 7.38 Mn
Sep 30, 2024 1.00 Mn
Jun 30, 2024 1.00 Mn
Mar 31, 2024 4.96 Mn
Dec 31, 2023 5.03 Mn
Sep 30, 2023 5.35 Mn
Jun 30, 2023 1.00 Mn
Mar 31, 2023 3.87 Mn
Dec 31, 2022 4.35 Mn
Sep 30, 2022 3.87 Mn
Jun 30, 2022 5.08 Mn
Mar 31, 2022 1.00 Mn
Dec 31, 2021 312,000.00
Sep 30, 2021 318,000.00